Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application
To assess epithelial barrier integrity, we cultured 3D premature intestinal organoids as monolayers in transwell inserts, treated them with EV39 or TGF1 and FGF2, and then measured the apical-to-basolateral passage of fluorescein isothiocyanate (FITC)-Dextran (4 kDa) across the epithelium
Treatment may include: Natural supplements to reduce mast cell activation Identification and avoidance of triggers A personalized gastrointestinal repair protocol to restore balance to the gut microbiome (the beneficial bacteria and other microorganisms living in the intestinal tract) and repair any damage to the intestinal lining A personalized detox protocol to support the bodys natural ability to detoxify itself Anti-inflammatory nutrients to reduce inflammation Peptides to support the bodys natural ability to heal itself ( see our previous post Protecting and Repairing the Body with BPC-157 ) The key to reducing mast cell activation is understanding the causes, triggers, and genetic susceptibilities
Think of this as giving repair cells a map and a compass rather than letting them wander
They were also 32% more likely to experience excess weight gain, meaning they put on more pounds than recommended during pregnancy
Rybelsus was approved next, in 2019, as the first GLP-1 for managing blood sugar in people with type 2 diabetes that does not need to be injected and can instead be taken by mouth in pill form
